Porto, Portugal
+351 960 245 977
fbnsantos@fbnsantos.com

Category: 23andme

Robotics | IoT

A Big Year for Biotech: Bugs as Drugs, Precision Gene Editing, and Fake Food

Speculations around whether biotech stocks are in a bubble remain undecided for the second year in a row. But one thing stands as indisputable—the field made massive progress during 2015,… read more
The post A Big Year for Biotech: Bugs as Drugs, …

Why we should all be thrilled about the FDA starting to embrace innovation

On Feb. 19, the U.S. Food and Drug Administration took a huge step towards patient-centric medicine when it approved the marketing of genetics testing company 23andMe’s carrier test for Bloom… read more